视网膜网状假性玻璃膜疣:进展为晚期年龄相关性黄斑变性的第三个黄斑风险特征:年龄相关性眼病研究2第30号报告
该研究对年龄相关性眼病研究(AREDS)和AREDS2两个临床试验队列进行事后分析,评估视网膜网状假性玻璃膜疣(RPD)作为独立风险因素与软性玻璃膜疣和色素异常同时考虑时对进展为晚期年龄相关性黄斑变性(AMD)的影响。结果显示在AREDS中RPD与晚期AMD风险升高相关(风险比2.15),但在AREDS2按人分析中无显著关联(风险比1.18);RPD与地图样萎缩的风险关联高于新生血管性AMD,且额外风险随严重程度分级变化明显。
要点
- AREDS中按人分析,同时考虑简化严重程度量表时,RPD与晚期AMD风险升高相关(风险比2.15)。
- AREDS2中按人分析RPD与晚期AMD风险无显著关联(风险比1.18,95%CI 0.90-1.56)。
- 两个队列中RPD与地图样萎缩的风险关联均高于新生血管性AMD。
核心结论
- 视网膜网状假性玻璃膜疣是进展为晚期年龄相关性黄斑变性的重要风险因素,尤其与地图样萎缩相关。
- RPD的额外风险随严重程度分级显著变化,在低/中度分级时风险显著增加,在更高分级时增加较少。
- RPD状态应纳入更新的AMD分类系统、风险计算器和临床试验。
研究设计与样本
- 对年龄相关性眼病研究(AREDS)和AREDS2两个临床试验队列进行事后分析。
- AREDS纳入基线无晚期AMD的6959只眼(3780名参与者),AREDS2纳入3355只眼(2056名参与者)。
主要发现
- AREDS按人分析,同时考虑简化严重程度量表时,RPD与晚期AMD风险升高相关(风险比2.15,95%CI 1.75-2.64)。
- AREDS按人分析,RPD相关风险在简化严重程度量表0-1、2、3、4级分别为风险比3.23(95%CI 1.60-6.51)、3.81(95%CI 2.38-6.10)、2.28(95%CI 1.59-3.27)、1.64(95%CI 1.20-2.24)。
- AREDS按眼分析,考虑9步量表时RPD与更高风险相关(风险比2.54,95%CI 2.07-3.13),1-6级风险比5.11(95%CI 3.93-6.66),7-8级风险比1.78(95%CI 1.43-2.22)。
- AREDS2按人分析RPD与更高风险无显著关联(风险比1.18,95%CI 0.90-1.56),按眼分析风险比1.57(95%CI 1.31-1.89)。
- 两个队列中RPD与地图样萎缩的风险关联均高于新生血管性AMD。
临床怎么用
- 原文结论提出RPD状态应纳入更新的AMD分类系统、风险计算器和临床试验。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze reticular pseudodrusen (RPD) as an independent risk factor for progression to late age-related macular degeneration (AMD), alongside traditional macular risk factors (soft drusen and pigmentary abnormalities) considered simultaneously. DESIGN: Post hoc analysis of 2 clinical trial cohorts: Age-Related Eye Disease Study (AREDS) and AREDS2. PARTICIPANTS: Eyes with no late AMD at baseline in AREDS (6959 eyes, 3780 participants) and AREDS2 (3355 eyes, 2056 participants). METHODS: Color fundus photographs (CFPs) from annual visits were graded for soft drusen, pigmentary abnormalities, and late AMD. Presence of RPD was from grading of fundus autofluorescence images (AREDS2) and deep learning grading of CFPs (AREDS). Proportional hazards regression analyses were performed, considering AREDS AMD severity scales (modified simplified severity scale [person] and 9-step scale [eye]) and RPD presence simultaneously. MAIN OUTCOME MEASURES: Progression to late AMD, geographic atrophy (GA), and neovascular AMD. RESULTS: In AREDS, for late AMD analyses by person, in a model considering the simplified severity scale simultaneously, RPD presence was associated with a higher risk of progression: hazard ratio (HR), 2.15 (95% confidence interval [CI], 1.75-2.64). However, the risk associated with RPD presence differed at different severity scale levels: HR, 3.23 (95% CI, 1.60-6.51), HR, 3.81 (95% CI, 2.38-6.10), HR, 2.28 (95% CI, 1.59-3.27), and HR, 1.64 (95% CI, 1.20-2.24), at levels 0-1, 2, 3, and 4, respectively. Considering the 9-step scale (by eye), RPD presence was associated with higher risk: HR, 2.54 (95% CI, 2.07-3.13). The HRs were 5.11 (95% CI, 3.93-6.66) at levels 1-6 and 1.78 (95% CI, 1.43-2.22) at levels 7 and 8. In AREDS2, by person, RPD presence was not associated with higher risk: HR, 1.18 (95% CI, 0.90-1.56); by eye, it was HR, 1.57 (95% CI, 1.31-1.89). In both cohorts, RPD presence carried a higher risk for GA than neovascular AMD. CONCLUSIONS: Reticular pseudodrusen represent an important risk factor for progression to late AMD, particularly GA. However, the added risk varies markedly by severity level, with highly increased risk at lower/moderate levels and less increased risk at higher levels. Reticular pseudodrusen status should be included in updated AMD classification systems, risk calculators, and clinical trials.
引用
- Agrón E, Domalpally A, Cukras CA, et al. Reticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report 30. Ophthalmology. 2022. PMID: 35660417. doi:10.1016/j.ophtha.2022.05.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。